Retraction
The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
Paper Information
Record ID:
53169
Author(s):
Journal:
Publication Date:
August 23, 2023
Retraction Date:
March 22, 2024
(1.7 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, Hebei Wild Animal Health Center, College of Life Sciences, Hebei Agricultural University , Baoding, China
- Baoding City Science and Technology Bureau , Baoding, China
- Tongzhou District Center For Animal Disease Control and Prevention , Beijing, China
- Department of Biochemistry and Biophysics, University of California , San Francisco, California, USA
Countries:
Article Type:
Publisher:
American Society for Microbiology
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1128/mbio.00106-24Additional Notes:
Replaced: https://journals.asm.org/doi/10.1128/mbio.00175-24
Citations (23)
23
Total Citations18
Post-Retraction(78.3%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
12
Within 1 year
0
After 2+ years
436
Days since retraction (latest)
Nanchangmycin suppresses influenza A virus infection by blocking endosomal acidification
Hao Zhang, Changhai Liu, Shuo Cai et al. (16 authors)
Acta Biochimica et Biophysica Sinica
Open Access
Published: Jun 2025
436 days after retraction
Development of a Universal Type A Influenza Viral RdRp-Induced Reporter System with Potential for Antiviral Drug Screening
Yuehong Chen, Wenguang Yang, L. Z. Liao et al. (13 authors)
ACS Infectious Diseases
Published: May 2025
431 days after retraction
Influenza Virus: Genomic Insights, Evolution, and its Clinical Presentation
Rajeev Jain, Himanshu Sharma, Lindomar Pena et al. (7 authors)
Microbial Pathogenesis
Published: May 2025
405 days after retraction
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication
Yuuki Kurebayashi, Y Wakabayashi, Tadanobu Takahashi et al. (8 authors)
Viruses
Open Access
Published: Apr 2025
379 days after retraction
Preparation and comprehensive preclinical study of Peramivir inhalation solution: Achieving accurate drug delivery
Chao Mei, Xinyi Cai, Pian Li et al. (9 authors)
Biomedicine & Pharmacotherapy
Published: Apr 2025
377 days after retraction
Assessment of the preventive effect of knockdown of cellular genes <i>NXF1</i>, PRPS1<i>PRPS1</i> and <i>NAA10</i> in influenza infection in an <i>in vitro</i> model
E. A. Pashkov, Dmitry A. Shikvin, George A. Pashkov et al. (9 authors)
Problems of Virology
Open Access
Published: Mar 2025
355 days after retraction
A concise review on influenza
Pratibha L. Ayanar, Simran M. Jamadar, Shweta R. Bharati et al. (5 authors)
International Journal of Research in Medical Sciences
Open Access
Published: Feb 2025
343 days after retraction
Antiviral effects and mechanism of Qi pi pill against influenza viruses
C. Zhang, Jing Gao, Meiyue Dong et al. (11 authors)
Animal Models and Experimental Medicine
Open Access
Published: Jan 2025
310 days after retraction
Advances and Challenges in Antiviral Development for Respiratory Viruses
Luis Adrián De Jesús‐González, Moisés León‐Juárez, Flor Itzel Lira-Hernández et al. (14 authors)
Pathogens
Open Access
Published: Dec 2024
5 citations
5 citations
284 days after retraction
Drug resistance and possible therapeutic options against influenza A virus infection over past years
Muhammad Asif Raza, Muhammad Awais Ashraf
Archives of Microbiology
Published: Nov 2024
2 citations
2 citations
228 days after retraction
Antiviral drug development by targeting RNA binding site, oligomerization and nuclear export of influenza nucleoprotein
Sankar Panthi, Jhen-Yi Hong, Roshan Satange et al. (6 authors)
International Journal of Biological Macromolecules
Published: Nov 2024
2 citations
2 citations
224 days after retraction
<scp>hnRNPs</scp> in antiviral innate immunity
Sofia Maceratessi, Natália G. Sampaio
Immunology
Open Access
Published: Aug 2024
4 citations
4 citations
138 days after retraction
Antiviral activity of organic solvent factions of <i>Houttuynia cordata</i> and <i>Lespedeza cuneata</i> against influenza A virus
Seon‐Jeong Kim, Ju Kim, Yo Han Jang
Journal of Applied Biological Chemistry
Open Access
Published: Jul 2024
124 days after retraction
Avian Influenza: Outbreak in Viet Nam in 2024
A T. Patel, Radheshyam Pal, Mithun Bhowmick et al. (6 authors)
Infectious Disorders - Drug Targets
Published: Jul 2024
1 citation
1 citation
102 days after retraction
Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023
Diana Angélica Franco-May, Jesús Gómez-Carballo, Gisela Barrera-Badillo et al. (10 authors)
Antiviral Research
Open Access
Published: May 2024
2 citations
2 citations
62 days after retraction
Synthetic Sialosides Terminated with 8‐<i>N</i>‐Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses
Bijoyananda Mishra, Yue Yuan, Hai Yu et al. (7 authors)
Angewandte Chemie International Edition
Open Access
Published: May 2024
1 citation
1 citation
46 days after retraction
Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications
Zhen-Xi Niu, Jing Hu, Jinfeng Sun et al. (4 authors)
European Journal of Medicinal Chemistry
Published: Apr 2024
16 citations
16 citations
35 days after retraction
Molecular Determinants of Drug Resistance and Mutation Patterns in Influenza Viruses Circulating in Poland Across Multiple Epidemic Seasons: Implications for Vaccination Strategies
Ewelina Hallmann, Aleksander Masny, Anna Poznańska et al. (6 authors)
Medical Science Monitor
Open Access
Published: Feb 2024
37 days before retraction
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1
Ahmed Magdy Khalil, Aitor Nogales, Luis Martínez‐Sobrido et al. (4 authors)
Frontiers in Cellular and Infection Microbiology
Open Access
Published: Feb 2024
8 citations
8 citations
46 days before retraction
The pathogenesis of influenza in intact alveoli: virion endocytosis and its effects on the lung’s air-blood barrier
J.L. Hook, Jahar Bhattacharya
Frontiers in Immunology
Open Access
Published: Jan 2024
2 citations
2 citations
56 days before retraction
Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro
Caolingzhi Tang, Julio Carrera Montoya, Svenja Fritzlar et al. (6 authors)
Virology
Open Access
Published: Dec 2023
4 citations
4 citations
101 days before retraction
Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses
Amrita Saha, Badri Narayan Acharya, Manmohan Parida et al. (6 authors)
Viruses
Open Access
Published: Oct 2023
2 citations
2 citations
143 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025